Next Article in Journal
Association of Thigh Muscle Strength with Texture Features Based on Proton Density Fat Fraction Maps Derived from Chemical Shift Encoding-Based Water–Fat MRI
Previous Article in Journal
Automatic Pharyngeal Phase Recognition in Untrimmed Videofluoroscopic Swallowing Study Using Transfer Learning with Deep Convolutional Neural Networks
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A SNaPshot Assay for Determination of the Mannose-Binding Lectin Gene Variants and an Algorithm for Calculation of Haplogenotype Combinations

by
Jana Mrazkova
1,2,
Petr Sistek
3,
Jan Lochman
1,4,
Lydie Izakovicova Holla
1,2,
Zdenek Danek
1,2,5 and
Petra Borilova Linhartova
1,2,5,6,7,*
1
Department of Pathophysiology, Faculty of Medicine, Masaryk University, Kamenice 753/5, 625 00 Brno, Czech Republic
2
Department of Stomatology, Institution Shared with St. Anne’s Faculty Hospital and Faculty of Medicine, Masaryk University, Pekarska 664/53, 656 91 Brno, Czech Republic
3
Secondary Technical School Brno, Purkynova, a Contributory Organization, Purkynova 97, 612 00 Brno, Czech Republic
4
Department of Biochemistry, Faculty of Science, Masaryk University, Kotlarska 267/2, 611 37 Brno, Czech Republic
5
Clinic of Maxillofacial Surgery, Institution Shared with the University Hospital Brno, Faculty of Medicine, Masaryk University, Jihlavska 20, 62500 Brno, Czech Republic
6
Institute of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University, Kamenice 753/5, 625 00 Brno, Czech Republic
7
Department of Molecular Pharmacy, Faculty of Pharmacy, Masaryk University, Palackeho tr. 1946/1, 612 00 Brno, Czech Republic
*
Author to whom correspondence should be addressed.
Diagnostics 2021, 11(2), 301; https://doi.org/10.3390/diagnostics11020301
Submission received: 2 November 2020 / Revised: 7 February 2021 / Accepted: 11 February 2021 / Published: 13 February 2021
(This article belongs to the Section Pathology and Molecular Diagnostics)

Abstract

:
Mannose-binding lectin (MBL) deficiency caused by the variability in the MBL2 gene is responsible for the susceptibility to and severity of various infectious and autoimmune diseases. A combination of six single nucleotide polymorphisms (SNPs) has a major impact on MBL levels in circulation. The aim of this study is to design and validate a sensitive and economical method for determining MBL2 haplogenotypes. The SNaPshot assay is designed and optimized to genotype six SNPs (rs1800451, rs1800450, rs5030737, rs7095891, rs7096206, rs11003125) and is validated by comparing results with Sanger sequencing. Additionally, an algorithm for online calculation of haplogenotype combinations from the determined genotypes is developed. Three hundred and twenty-eight DNA samples from healthy individuals from the Czech population are genotyped. Minor allele frequencies (MAFs) in the Czech population are in accordance with those present in the European population. The SNaPshot assay for MBL2 genotyping is a high-throughput, cost-effective technique that can be used in further genetic-association studies or in clinical practice. Moreover, a freely available online application for the calculation of haplogenotypes from SNPs is developed within the scope of this project.

1. Introduction

Mannose-binding lectin (MBL, also known as mannose-binding protein, mannan-binding protein/lectin, Collectin 1, MBP1, or mannose-binding protein C) is a crucial part of innate immunity. It is classified as an acute-phase protein because its plasma level increases after the onset of inflammation. MBL belongs to a group of soluble pattern-recognition receptors that can recognize pathogen-associated molecular patterns and damage-associated molecular patterns released from activated cells, cells undergoing apoptosis or necrosis, or host cells with altered surface glycosylation patterns related to cancer phenotypes [1,2,3,4,5]. MBL trimers and tetramers are the forms most common in blood circulation due to their high effectiveness in complement activation after interaction with MBL-associated serine proteases (MASP 1, −2, −3) [6,7,8,9]. Furthermore, MBL works as an opsonin and enables phagocytosis independently on the complement [1,4].
The concentration of the functional MBL in blood circulation is affected by the MBL2 gene variant located on chromosome 10q11.2-21. Alleles B (rs1800450, NM_000242.2:c.161G>A), C (rs1800451, NM_000242.2:c.170G>A) or D (rs5030737, NM_000242.2:c.154C>T), possessing single nucleotide polymorphisms (SNPs) in exon 1, cause amino acid substitution of Gly54Asp, Gly57Glu, or Arg52Cys, respectively. These variants lead to the production of a structurally impaired protein. As a result of the substitutions higher MBL oligomers disintegrate more rapidly into lower oligomers, which are no longer capable of activating the complement system. These alleles are summarily called alleles O, whereas the allele without substitution (normal allele) is called allele A. Alleles H/L (rs11003125) and X/Y (rs7096206) carrying SNPs localized in the promoter region (NM_000242.2:c.-619C>G and NM_000242.2:c.-290C>G, respectively), and allele P/Q (rs7095891) with the SNP in the 5’ untranslated region (5’UTR) of exon 1 (NM_000242.2:c.-66C>T), alter MBL2 transcription and translation, directly affecting the MBL plasma level [8,10].
Due to strong linkage disequilibrium (LD) among the six SNPs and variation of these SNPs’ frequencies among ethnic groups, only seven MBL secretor haplotypes (allele combinations) are relatively common. HYPA and LYQA haplotypes are associated with high MBL serum levels, LYPA with intermediate levels, and LXPA with low MBL production. Defect haplotypes LYPB, LYQC and HYPD are responsible for expressing undetectable amounts of MBL [10,11]. Nevertheless, the MBL level in circulation depends on a combination of two haplotypes; for example, the HYPA/LXPA haplogenotype is responsible for medium MBL levels while LYPB, LYQC or HYPD combined with LYPA leads to low MBL levels in the serum [12]. MBL deficiency (a common human immunodeficiency, 5–30% of the population is affected) has been associated with increased susceptibility toward infectious diseases and autoimmune diseases [13]. Therefore, determining genotypes of all six SNPs and the resulting haplogenotypes is necessary for predicting the MBL phenotype.
The SNaPshot assay is a minisequencing method widely used for simultaneous detection of polymorphisms in individual genes [14,15] or the whole genome [16]. The assay is sensitive and straightforward, and the results can be automatically evaluated using software. Therefore, this method is very well suited for multiple SNP genotyping in the MBL2 gene.
The aim of this work is to develop a low cost, accurate, and reliable method for genotyping six functional SNPs in the MBL2 gene that could be utilized both in research and clinical practice, and to use this method for the genotyping of 328 samples of healthy individuals from the Czech population. Furthermore, we develop a custom-made online application for the calculation of haplogenotypes in this study.

2. Materials and Methods

2.1. Study Subjects and Sampling

To optimize the originally designed SNaPshot assay, subjects meeting the inclusion criteria were selected from the pool of patients of the Institutions shared with St. Anne’s Faculty Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic. Inclusion criteria for this study were: adult (aged 18 years and higher), Czech nationality, systemic health, and willingness to participate. Exclusion criteria comprised the inability to give consent, blood relationship to another participant, history of systemic diseases (such as diabetes mellitus, coronary artery diseases, malignancies, immunodeficiency disorders), immunosuppression attributable to medication, or concurrent illness.
Three hundred and twenty-eight individuals with good systemic health (mean age ± standard deviation of 34.0 ± 13.5 years, 192 women and 136 men) were enrolled in this study; for demographic data, see Table 1. Peripheral blood was collected from each subject in a tube containing 0.5 M ethylenediaminetetraacetic acid (EDTA) and stored at −20 °C within 30 min of collection.

2.2. DNA Isolation

Genomic DNA was isolated from peripheral blood leukocytes using proteinase K digestion of cells and isopropanol-phenol-chloroform DNA extraction according to the standard protocol [17]. DNA concentration and purity were determined using a spectrophotometer NanoDrop 1000 (Thermo Fisher Scientific, Waltham, MA, USA) and all DNA samples were diluted to working concentrations of 50 ng/μL.

2.3. SNaPshot Assay

The SNaPshot assay was applied for simultaneous determination of six single nucleotide polymorphisms (SNPs) in the MBL2 gene (rs11003125, rs7096206, rs7095891, rs1800450, rs1800451, rs5030737). The part of the MBL2 sequence carrying all SNPs of interest was determined using commercial Sanger sequencing (Eurofins Genomics Germany GmbH, Ebersberg, Germany) in 8 samples randomly chosen from the sample pool. These samples served as controls for the optimization of the SNaPshot assay.

2.3.1. Primer Design

Forward and reverse primers, 5’-CTGTAAACAGATTCCCCCAGTA-3’ and 5’-GGAGGATTCAAGGCAAGTTTTC-3’, respectively, used in the amplification polymerase chain reaction (PCR), were originally designed in the Primer3Plus program (https://primer3plus.com/cgi-bin/dev/primer3plus.cgi (accessed on 2 November 2020)). The potential formation of homo/heterodimers and hairpin structures were checked by the IDT OligoAnalyzer (https://eu.idtdna.com/calc/analyzer (accessed on 2 November 2020)); the specificity of selected primers was tested using NCBI Primer-BLAST (https://www.ncbi.nlm.nih.gov/tools/primer-blast/ (accessed on 2 November 2020)). One primer specific for single-base extension (SBE) reaction was designed for each single nucleotide polymorphism (SNP) (rs11003125, rs7096206, rs7095891, rs1800450, rs1800451, rs5030737) using a sequence from the NCBI dbSNP database (https://www.ncbi.nlm.nih.gov/projects/SNP/ (accessed on 2 November 2020)). Poly-T tails of different lengths were added to each SBE primer, and analysis of hairpin and dimer formation was performed. SBE primers were commercially synthesized and purified by high-performance liquid chromatography (Integrated DNA Technologies, Leuven, Belgium). The information about primers is listed in Table 2.

2.3.2. Amplification PCR

Ten microliters of the PCR mixture contained a 1× Taq buffer with (NH4)2SO4 and without MgCl2, a 0.3 mM concentration of each deoxynucleotide (dNTP), a 0.25 μM concentration of each primer, 3 mM of MgCl2, 0.06 U of Taq DNA polymerase (Thermo Fisher Scientific, Waltham, MA, USA), and 2 μL of genomic DNA (of concentration 50 ng/μL). Cycling conditions were initial denaturation at 95 °C for 3 min., then 30 cycles of 95 °C for 30 s, 58 °C for 30 s and 72 °C for 90 s, followed by a final extension at 72 °C for 10 min. The formation of a correct PCR amplicon (1334 bp length) was checked by electrophoresis in 1% agarose gel after 1 hour at 90 V. Three microliters of the PCR mixture were treated with 5 U of Exonuclease I and 1.2 U of Shrimp Alkaline Phosphatase. The mixture was incubated at 37 °C for 1 hour, and the enzymes were inactivated by incubation at 85 °C for 15 min.

2.3.3. Single-Base Extension (SBE) Reaction

Five microliters of the single-base extension (SBE) reaction mixture contained 0.5 μL of the SNaPshot Multiplex Ready Reaction Mix (ABI PRISM® SNaPshot™ Multiplex kit, Applied Biosystems, Foster City, CA, USA), 2 μL of the PCR mixture after enzymatic treatment, and 1 μL of the SBE primer mix (concentrations of individual primers are listed in Table 2). Five microliters of positive and negative control reactions were prepared by mixing an appropriate volume of water, 0.5 μL of the SNaPshot Multiplex Ready Reaction Mix, and 0.5 μL of the SNaPshot Multiplex Control Primer Mix with and without 1 μL of the SNaPshot Multiplex Control Template, respectively. The SBE primer mix control reaction was prepared by mixing 3.5 μL of water and 0.5 μL of the SNaPshot Multiplex Ready Reaction Mix with 1 μL of the SBE primer mix without any template. Cycling conditions were 30 cycles at 96 °C for 10 s, 50 °C for 5 s, and 60 °C for 30 s. The SBE reaction mixture was treated with 1 U of Shrimp Alkaline Phosphatase and incubated at 37 °C for 1 h, which was followed by enzyme inactivation at 85 °C for 15 min.

2.3.4. Capillary Electrophoresis

Zero point five microliters of the treated single-base extension (SBE) reaction mixture were mixed with 9.4 μL of Super-DI Formamide v2 and 0.1 μL of GeneScan™ 120 LIZ™ size standard (Applied Biosystems, Foster City, CA, USA). The mixture was denatured at 95 °C for 5 min, immediately chilled at −20 °C for 3 min, centrifuged and kept at 4 °C. The capillary electrophoresis was performed on an automated sequencer ABI 3130-Avant Genetic Analyzer (Applied Biosystems, Foster City, CA, USA) with a 22 cm long capillary (Applied Biosystems, Foster City, CA, USA) filled with NimaPOP-4 (NimaGen, Nijmegen, The Netherlands). The injection at 1.0 kV lasted 10 s. The electrophoresis was performed at 15 V, 60 °C, and 5 μA for 360 s. The laser was set at a constant power of 15 mW. Data were collected by the Data Collection software (version 3.0, Applied Biosystems, Foster City, CA, USA) and the results were analyzed using the GeneMapper ID software (version 3.2, Applied Biosystems, Foster City, CA, USA).

2.4. Sanger Sequencing

Eighty-three samples randomly chosen from the pool were sequenced using a Big Dye™ Terminator v3.1 Cycle Sequencing kit (Applied Biosystems, Foster City, CA, USA). PCR products treated with Exonuclease I and Shrimp Alkaline Phosphatase were used as templates, and an ethanol/EDTA precipitation procedure was used for purification of sequencing reactions. The capillary electrophoresis was performed on an automated sequencer ABI 3130-Avant Genetic Analyzer with a 36 cm long capillary filled with NimaPOP-7 (NimaGen, Nijmegen, The Netherlands). Data were collected by the Data Collection program and results were analyzed using the Sequencing Analysis program (version 5.4, Applied Biosystems, Foster City, CA, USA).

2.5. Calculation of Haplogenotype Combinations

An algorithm for calculating haplogenotype combinations (Haplogenotype Calculator) from determined genotypes was developed. Combinations from 2 to 10 single nucleotide polymorphisms (SNPs) were calculated. When individual boxes (Homozygote 1, Heterozygote, Homozygote 2) were filled with particular genotypes, the program created all possible combinations of these genotypes (background data set) and each combination in the background data set had a unique number. During the next step, the program compared the genotype combination of the real sample (determined experimentally) with the background data set. When a match was found, the unique number of the corresponding genotype combination was entered into the output datasheet. The whole sample set was analyzed this way. When 4 SNPs are investigated, for example, 11 possible combinations are calculated (such as SNP1+SNP2, SNP1+SNP3, SNP1+SNP4, SNP2+SNP3, SNP2+SNP4, SNP3+SNP4; SNP1+SNP2+SNP3, SNP1+SNP2+SNP4, SNP1+SNP3+SNP4, SNP2+SNP3+SNP4; SNP1+SNP2+SNP3+SNP4). When 10 SNPs are calculated, the application generates all allowed combinations of 2–10 SNPs. This algorithm has been made freely available as an online application on the URL http://78.128.251.116/ (accessed on 2 November 2020). The website is hosted by MetaCentrum VO (https://metavo.metacentrum.cz/ (accessed on 2 November 2020)). First, the spreadsheet containing the specific diagram must be downloaded from the main page of the website (link “scheme”). Then, an XML (Extensible Markup Language) file must be generated from this spreadsheet containing sample IDs and experimentally determined genotypes of SNPs. The XML file is uploaded to the application, the number of SNPs is selected, individual fields are filled with the allele combination for each SNP, and the calculation is run. The output datasheet is saved as an *.xlsx file. According to the number of analyzed SNPs, the output file contains separated sheets with combinations of SNP pairs, SNP triplets, SNP quadruplets etc. The calculation time depends on the number of SNPs and especially on the number of analyzed samples in the sample pool; it can take up to 1 hour. A step-by-step manual on the use of this application for calculating haplogenotypes is available on the main page of the website.

2.6. Statistical Analysis

Hardy-Weinberg equilibrium, linkage disequilibrium, minor allele frequencies and haplotype frequencies were calculated in the Haploview software (version 4.2, Broad Institute, Cambridge, MA, USA) [19].

3. Results

3.1. Design and Optimization of the SNaPshot Assay

The SNaPshot assay was developed and optimized for simultaneous detection of six single nucleotide polymorphisms (SNPs) in the MBL2 gene. PCR was designed to amplify a single amplicon carrying all SNPs of interest. The PCR was optimized by adjusting the concentrations of the primers (0.3–0.5 μM) and MgCl2 (1–6 mM) and the cycling conditions (gradient of Ta 54–62 °C, with a 3–5 min. duration of initial denaturation, for 25–45 cycles). To minimize reaction costs, the volume of the SNaPshot Multiplex Ready Reaction Mix added to the single-base extension (SBE) reaction was reduced, as well as the total volumes of the SBE and PCR reactions. Considering the positions of three polymorphisms in the exon 1, which are very close to each other, two out of six specific primers used in the SBE reaction were synthesized with degenerate bases incorporated into their sequence (Table 2).
Six singleplex SBE reactions were performed with a PCR template to determine the position of the peaks of individual SNP alleles in the electropherogram and to check for peaks caused by non-specific annealing. A multiplex SBE reaction with the SBE primer mix, and without the PCR template, served to check for the formation of heterodimer products. Overlapping of the peaks of the three shortest SBE primers was observed after analysis of the multiplex SBE reaction; nevertheless, it was still possible to determine genotypes due to the color difference of incorporated bases belonging to the particular SNPs (Figure 1). Concentrations of specific primers were adjusted, and the number of SBE reaction cycles was increased to obtain more balanced peak heights.
Finally, the panel and bins for allele identification were entered into the GeneMapper program to enable the automatic analysis.

3.2. Mannose-Binding Lectin Gene (MBL2) Genotyping

Altogether, 328 samples were successfully genotyped by the SNaPshot assay. Frequencies of the variant alleles of all six MBL2 gene single nucleotide polymorphisms (SNPs) (rs1800451, rs1800450, rs5030737, rs7095891, rs7096206, rs11003125) were in accordance with the Hardy-Weinberg equilibrium (p = 1.00, 0.73, 0.80, 0.12, 0.38, 0.74, respectively). The pairwise linkage disequilibrium (LD) was calculated, and all studied MBL2 SNPs were in the LD block (Supplementary Figure S1). Minor allele frequencies (MAFs) in the Czech population corresponded to MAFs from the 1000 Genomes Project Phase 3 (NCBI database dbSNP) for the European population. MAFs of all studied MBL2 SNPs in other populations also have been included in Table 3 for comparison. Calculated haplotype frequencies were similar to those reported in the Danish population (Table 4).

3.3. Validation of the SNaPshot Assay Results

To validate results obtained by the developed SNaPshot assay, we used classical Sanger sequencing of 83 randomly selected samples. A perfect match (100% fit) was found between genotypes determined by Sanger sequencing and the SNaPshot assay.

3.4. Calculation of Haplogenotype Combinations

The Haplogenotype Calculator created within the scope of this study was used for calculation of haplogenotype combinations from six single nucleotide polymorphisms (SNPs) in the MBL2 gene determined in 328 samples. Distribution of the MBL2 haplogenotypes calculated from all six SNPs among samples from healthy individuals is listed in Table 5.

4. Discussion

Here, the SNaPshot assay was introduced for simultaneous genotyping of the six functional polymorphisms within the MBL2 gene. Similar assays have recently been used but none of these was designed for genotyping all six single nucleotide polymorphisms (SNPs) [21,22,23,24]. Due to the proximity of the individual analyzed SNPs, we performed a singleplex PCR reaction, which subsequently served as a template for the single-base extension (SBE) reaction. We have achieved consistent results within the optimized SBE reaction, even with a significantly minimized volume (0.5 μL) of the commercially used mix. Regarding a small portion of analyzed samples (4.9%), non-specific peaks in electropherograms were observed. These peaks were at the same positions and colors as peaks of alleles D and Q, which could be potentially problematic during the consequent analysis. However, we eliminated the risk of inaccurate allele identification by setting the heterozygote balance (the min peak height ratio) in the GeneMapper software. All the problematic samples were stored at +4 °C after DNA isolation for more than six months, or their stock solutions were stored at −20 °C for more than two years. Thus, it is very likely that these samples contained partially degraded DNA, which could adversely affect the SNaPshot assay effectiveness with potential amplification bias.
The choice of an appropriate method for genotyping SNPs in clinical or research laboratories depends on several factors, including the number and type of samples and the available quantity/quality of the analyzed DNA. Also, financial, material, and instrumentation requirements, or the availability of a commercial genotyping service, are considered. During MBL2 genotyping, the proximity of the polymorphisms in the MBL2 exon 1 is a crucial factor that must be taken into account in selecting the method. A combination of methods suitable for determining SNPs in the promoter and the first exon often needs to be applied in MBL2 genotyping [25,26].
Up to this day, a wide spectrum of other methods have been used for detection of MBL2 gene variants, including commercially available TaqMan assays [27], high-resolution melt analysis (HRMA) [28], reverse hybridization with membrane-immobilized sequence-specific oligonucleotide probes (reverse PCR-SSOP) [29], PCR with sequence-specific primers (SSP-PCR) [30,31], PCR and restriction-fragment length polymorphism (PCR-RFLP) analysis [32], an oligonucleotide ligation assay [33,34], a single-strand conformation polymorphism technique (PCR-SSCP) [35], the iPLEX assay on a MassArray system [36], Sanger sequencing [37], and pyrosequencing [38].
Genotyping methods based on PCR or enzymatic digestion of specific PCR products with analysis of genotypes on agarose/acrylamide gel are widely used due to their simplicity and low requirement for materials and instrumentation. Conversely, these techniques are laborious and, in effect, not suitable for high-throughput genotyping. Furthermore, the low sensitivity and robustness of these methods might pose a problem. A TaqMan assay, which belongs to high-throughput methods, is quite simple, fast, and sensitive. However, analyses of interrogated polymorphisms are performed in separate reactions, leading to a higher consumption of the template DNA. The assay can be multiplexed but, in view of the proximity of the individual SNPs in exon 1 of MBL2 it can be very difficult, if not impossible. This could lead to the need for several individual reactions, which would render the analysis expensive.
Conversely, the proximity of SNPs in exon 1 become an advantage when the pyrosequencing method is used for the genotyping of these SNPs. Pyrosequencing and HRMA are very rapid and sensitive methods; however, four (pyrosequencing) and five (HRMA) analyses, respectively, are needed to determine six MBL2 polymorphisms, which increases the consumption of the template DNA.
Unlike these methods, the SNaPshot minisequencing method is at present the only method capable of reliable automated determination of the complete MBL2 haplogenotype in a single analysis and is less prone to heterozygosity loss than Sanger sequencing [39]. The high sensitivity and short analysis time also count among the benefits of this method [40]. The comparison of methods used for MBL2 genotyping is summarized in Table 6.
During our study, 328 samples from healthy individuals from the Czech population were genotyped using the SNaPshot assay. Minor allele frequencies (MAFs) of all six MBL2 SNPs in the healthy Czech population were similar to the MAFs deposited in the database for the European population (Table 3). The calculated haplotype frequencies were consistent with those determined in the Danish [20] and Czech [42] populations (Table 4). A rare secretor haplotype LYQB was detected in the sample pool. To our knowledge, it is the first evidence of this haplotype in the Czech population. Additionally, MBL2 haplogenotypes from six SNPs were determined in the Czech population for the first time (Table 5).
Concerning some cases, diseases can be associated with haplotypes (i.e., with the sequential allele arrangement of particular SNPs) or diplotypes (pairs of haplotypes) rather than alleles or genotypes alone [47]. Furthermore, the frequency of alleles can be in a strong Hardy-Weinberg Disequilibrium in sample sets of subjects with investigated diseases. Regarding such instances, diplotype-based association analyses are more powerful than haplotype-based analyses [48]. Methods used for genotyping are unable to determine haplotypes, although methods capable of identifying diplotypes have been developed [49]. Therefore, several programs for haplotype phasing (haplotype estimation from determined genotypes) [50,51], calculation of haplotype frequencies and association tests [52,53], and diplotype-based association analysis [54] have been developed.
Conversely, haplogenotypes (combinations of unphased genotypes) have been used in association studies [55]. Here, a simple online application for the calculation of haplogenotypes by combining determined genotypes of two to ten SNPs has been prepared to facilitate further statistical analyses.

5. Conclusions

A novel SNaPshot assay for detection of six single nucleotide polymorphisms (SNPs) in the MBL2 gene was developed, optimized, and used for the genotyping of 328 samples from healthy individuals from the Czech population. Results of the assay were validated through comparison with results of sequencing analysis, which were concordant. Calculated minor allele frequencies (MAFs) were in accordance with MAFs for the European population deposited in the database. This high-throughput, cost-effective, and accurate method, therefore, can be used in further association studies as well as in clinical practice. The main limitation of the method is the quality of the DNA in tested samples. Moreover, the freely available online application developed for this study can be employed for the calculation of haplogenotype combinations from up to 10 genotypes.

Supplementary Materials

The following are available online at https://www.mdpi.com/2075-4418/11/2/301/s1, Figure S1: Linkage disequilibrium (LD) maps for 6 single nucleotide polymorphisms in the mannose-binding lectin gene (MBL2).

Author Contributions

J.M. and J.L. are responsible for the methodology, validation, formal analysis, investigation, data curation and visualization. P.S. programmed the algorithm and managed the online application. J.M. prepared the original draft. J.L., L.I.H., Z.D. and P.B.L. reviewed and edited the manuscript. P.B.L. is responsible for the conceptualization, methodology, validation, formal analysis, investigation, data curation and visualization. All authors have read and agreed to the published version of the manuscript.

Funding

The study was supported by the Ministry of Health of the Czech Republic, grants No. NU-20-08-00205 and NV17-30439A, the project MUNI/A/1428/2019, and funds from the Faculty of Medicine MU to a junior researcher (Zdenek Danek, ROZV/28/LF4/20). All rights reserved.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Committee for Ethics of the Faculty of Medicine, Masaryk University Brno, and St. Anne’s Faculty Hospital (1G/2017, 24 June 2016).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Acknowledgments

Computational resources were provided by the CESNET LM2015042 and the CERIT Scientific Cloud LM2015085, provided under the program “Projects of Large Research, Development, and Innovations Infrastructures”.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Dommett, R.M.; Klein, N.; Turner, M.W. Mannose-Binding Lectin in Innate Immunity: Past, Present and Future. Tissue Antigens 2006, 68, 193–209. [Google Scholar] [CrossRef] [PubMed]
  2. Takahashi, K.; Ip, W.E.; Michelow, I.C.; Ezekowitz, R.A.B. The Mannose-Binding Lectin: A Prototypic Pattern Recognition Molecule. Curr. Opin. Immunol. 2006, 18, 16–23. [Google Scholar] [CrossRef]
  3. Ip, E.W.K.; Takahashi, K.; Ezekowitz, A.R.B.; Stuart, L.M. Mannose-Binding Lectin and Innate Immunity. Immunol. Rev. 2009, 230, 9–21. [Google Scholar] [CrossRef] [PubMed]
  4. Cedzyński, M.; Kilpatrick, D.C.; Świerzko, A.S. Mannose-Binding Lectin. In The Complement FactsBook; Elsevier: Amsterdam, The Netherlands, 2018; pp. 33–43. ISBN 978-0-12-810420-0. [Google Scholar]
  5. dos Santos Silva, P.M.; de Oliveira, W.F.; Albuquerque, P.B.S.; dos Santos Correia, M.T.; Coelho, L.C.B.B. Insights into Anti-Pathogenic Activities of Mannose Lectins. Int. J. Biol. Macromol. 2019, 140, 234–244. [Google Scholar] [CrossRef] [PubMed]
  6. Kjaer, T.R.; Thiel, S.; Andersen, G.R. Toward a Structure-Based Comprehension of the Lectin Pathway of Complement. Mol. Immunol. 2013, 56, 222–231. [Google Scholar] [CrossRef] [Green Version]
  7. Kjaer, T.R.; Jensen, L.; Hansen, A.; Dani, R.; Jensenius, J.C.; Dobó, J.; Gál, P.; Thiel, S. Oligomerization of Mannan-Binding Lectin Dictates Binding Properties and Complement Activation. Scand. J. Immunol. 2016, 84, 12–19. [Google Scholar] [CrossRef] [Green Version]
  8. Garred, P.; Genster, N.; Pilely, K.; Bayarri-Olmos, R.; Rosbjerg, A.; Ma, Y.J.; Skjoedt, M.-O. A Journey through the Lectin Pathway of Complement-MBL and Beyond. Immunol. Rev. 2016, 274, 74–97. [Google Scholar] [CrossRef]
  9. Dobó, J.; Kocsis, A.; Gál, P. Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases. Front. Immunol. 2018, 9, 1851. [Google Scholar] [CrossRef]
  10. Heitzeneder, S.; Seidel, M.; Förster-Waldl, E.; Heitger, A. Mannan-Binding Lectin Deficiency—Good News, Bad News, Doesn’t Matter? Clin. Immunol. 2012, 143, 22–38. [Google Scholar] [CrossRef]
  11. Verdu, P.; Barreiro, L.B.; Patin, E.; Gessain, A.; Cassar, O.; Kidd, J.R.; Kidd, K.K.; Behar, D.M.; Froment, A.; Heyer, E.; et al. Evolutionary Insights into the High Worldwide Prevalence of MBL2 Deficiency Alleles. Hum. Mol. Genet. 2006, 15, 2650–2658. [Google Scholar] [CrossRef]
  12. Seyfarth, J.; Garred, P.; Madsen, H.O. The ‘Involution’ of Mannose-Binding Lectin. Hum. Mol. Genet. 2005, 14, 2859–2869. [Google Scholar] [CrossRef] [PubMed]
  13. Bouwman, L.H.; Roep, B.O.; Roos, A. Mannose-Binding Lectin: Clinical Implications for Infection, Transplantation, and Autoimmunity. Hum. Immunol. 2006, 67, 247–256. [Google Scholar] [CrossRef]
  14. Hou, J.; Ding, J.; Li, L.; Peng, Y.; Gao, X.; Guo, Z. Association of Sirtuin 1 Gene Polymorphisms with Nephrolithiasis in Eastern Chinese Population. Ren. Fail. 2019, 41, 34–41. [Google Scholar] [CrossRef] [Green Version]
  15. Geng, Y.; Li, L.; Wang, X.; He, F.; Zhou, Y.; Yang, M.; Xu, Y. Interleukin-10 Polymorphisms Affect the Key Periodontal Pathogens in Chinese Periodontitis Patients. Sci. Rep. 2018, 8, 9068. [Google Scholar] [CrossRef] [Green Version]
  16. Zhao, M.; Zhang, Y.; Liu, Y.; Sun, G.; Tian, H.; Hong, L. Polymorphisms in MAPK9 (Rs4147385) and CSF1R (Rs17725712) Are Associated with the Development of Inhibitors in Patients with Haemophilia A in North China. Int. J. Lab. Hematol. 2019, 41, 572–577. [Google Scholar] [CrossRef] [PubMed]
  17. Sambrook, J.; Fritsch, E.; Maniatis, T. Molecular Cloning: A Laboratory Manual: Volume 2, 2nd ed.; Cold Spring Harbor: New York, NY, USA, 1989; ISBN 978-0-87969-309-1. [Google Scholar]
  18. Świerzko, A.S.; Cedzyński, M. The Influence of the Lectin Pathway of Complement Activation on Infections of the Respiratory System. Front. Immunol. 2020, 11, 585243. [Google Scholar] [CrossRef]
  19. Barrett, J.C.; Fry, B.; Maller, J.; Daly, M.J. Haploview: Analysis and Visualization of LD and Haplotype Maps. Bioinformatics 2005, 21, 263–265. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Steffensen, R.; Thiel, S.; Varming, K.; Jersild, C.; Jensenius, J.C. Detection of Structural Gene Mutations and Promoter Polymorphisms in the Mannan-Binding Lectin (MBL) Gene by Polymerase Chain Reaction with Sequence-Specific Primers. J. Immunol. Methods 2000, 241, 33–42. [Google Scholar] [CrossRef]
  21. Zhang, N.; Zhuang, M.; Ma, A.; Wang, G.; Cheng, P.; Yang, Y.; Wang, X.; Zhang, J.; Chen, X.; Lu, M. Association of Levels of Mannose-Binding Lectin and the MBL2 Gene with Type 2 Diabetes and Diabetic Nephropathy. PLoS ONE 2013, 8, e83059. [Google Scholar] [CrossRef] [Green Version]
  22. Yarden, J.; Radojkovic, D.; De Boeck, K.; Macek, M., Jr.; Zemkova, D.; Vavrova, V.; Vlietinck, R.; Cassiman, J.-J.; Cuppens, H. Polymorphisms in the Mannose Binding Lectin Gene Affect the Cystic Fibrosis Pulmonary Phenotype. J. Med. Genet. 2004, 41, 629–633. [Google Scholar] [CrossRef] [Green Version]
  23. Laisk, T.; Peters, M.; Saare, M.; Haller-Kikkatalo, K.; Karro, H.; Salumets, A. Association of CCR5, TLR2, TLR4 and MBL Genetic Variations with Genital Tract Infections and Tubal Factor Infertility. J. Reprod. Immunol. 2010, 87, 74–81. [Google Scholar] [CrossRef]
  24. Tarova, E.T.; Polakova, H.; Kayserova, H.; Celec, P.; Zuzulova, M.; Kadasi, L. Study of the Effect of DNA Polymorphisms in the Mannose-Binding Lectin Gene (MBL2) on Disease Severity in Slovak Cystic Fibrosis Patients. Gen. Physiol. Biophys. 2012, 30, 373–378. [Google Scholar] [CrossRef] [Green Version]
  25. Sokołowska, A.; Świerzko, A.S.; Gajek, G.; Gołos, A.; Michalski, M.; Nowicki, M.; Szala-Poździej, A.; Wolska-Washer, A.; Brzezińska, O.; Wierzbowska, A.; et al. Associations of Ficolins and Mannose-Binding Lectin with Acute Myeloid Leukaemia in Adults. Sci. Rep. 2020, 10, 10561. [Google Scholar] [CrossRef] [PubMed]
  26. Swale, A.; Miyajima, F.; Kolamunnage-Dona, R.; Roberts, P.; Little, M.; Beeching, N.J.; Beadsworth, M.B.J.; Liloglou, T.; Pirmohamed, M. Serum Mannose-Binding Lectin Concentration, but Not Genotype, Is Associated With Clostridium Difficile Infection Recurrence: A Prospective Cohort Study. Clin. Infect. Dis. 2014, 59, 1429–1436. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Madsen, E.C.; Levy, E.R.; Madden, K.; Agan, A.A.; Sullivan, R.M.; Graham, D.A.; Randolph, A.G. Mannose-Binding Lectin Levels in Critically Ill Children With Severe Infections. Pediatr. Crit. Care Med. 2017, 18, 103–111. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Su, C.; Lin, Y.; Cai, L.; Mao, Q.; Niu, J. Association between Mannose-Binding Lectin Variants, Haplotypes and Risk of Hepatocellular Carcinoma: A Case-Control Study. Sci. Rep. 2016, 6, 32147. [Google Scholar] [CrossRef] [Green Version]
  29. Puente, M.; Fariñas-Alvarez, C.; Moreto, A.; Sánchez-Velasco, P.; Ocejo-Vinyals, J.G.; Fariñas, M.C.; on behalf of SCT Team. Low Pre-Transplant Levels of Mannose-Binding Lectin Are Associated with Viral Infections and Mortality after Haematopoietic Allogeneic Stem Cell Transplantation. BMC Immunol. 2019, 20, 40. [Google Scholar] [CrossRef] [Green Version]
  30. Kalia, N.; Singh, J.; Sharma, S.; Arora, H.; Kaur, M. Genetic and Phenotypic Screening of Mannose-Binding Lectin in Relation to Risk of Recurrent Vulvovaginal Infections in Women of North India: A Prospective Cohort Study. Front. Microbiol. 2017, 8. [Google Scholar] [CrossRef] [Green Version]
  31. Losada López, I.; García Gasalla, M.; González Moreno, J.; Serrano, A.; Domínguez Valdés, F.J.; Milà, J.; Payeras, A. Mannose Binding Lectin Polymorphisms in Systemic Lupus Erythematosus in Spain. Eur. J. Inflamm. 2016, 14, 78–85. [Google Scholar] [CrossRef] [Green Version]
  32. Pągowska-Klimek, I.; Świerzko, A.S.; Michalski, M.; Moll, M.; Szala-Poździej, A.; Sokołowska, A.; Krajewski, W.R.; Cedzyński, M. Mannose-Binding Lectin (MBL) Insufficiency Protects against the Development of Systemic Inflammatory Response after Pediatric Cardiac Surgery. Immunobiology 2016, 221, 175–181. [Google Scholar] [CrossRef]
  33. Gu, X.; Ji, Q.; Wang, H.; Jiang, M.; Yang, J.; Fang, M.; Wang, M.; Gao, C. Genetic Variants of Mannose-Binding Lectin 2 Gene Influence Progression and Prognosis of Patients with Hepatitis B Virus Infection in China. Clin. Res. Hepatol. Gastroenterol. 2016, 40, 614–621. [Google Scholar] [CrossRef] [PubMed]
  34. Monsey, L.; Best, L.G.; Zhu, J.; DeCroo, S.; Anderson, M.Z. The Association of Mannose Binding Lectin Genotype and Immune Response to Chlamydia Pneumoniae: The Strong Heart Study. PLoS ONE 2019, 14, e0210640. [Google Scholar] [CrossRef] [PubMed]
  35. Amiri, A.; Sabooteh, T.; Shahsavar, F.; Anbari, K.; Pouremadi, F. Mannose-Binding Lectin (MBL) Gene Polymorphisms in Susceptibility to Pulmonary Tuberculosis among the Lur Population of Lorestan Province of Iran. Genom. Data 2017, 12, 146–150. [Google Scholar] [CrossRef] [PubMed]
  36. Ouyang, Y.; Zhu, L.; Shi, M.; Yu, S.; Jin, Y.; Wang, Z.; Ma, J.; Yang, M.; Zhang, X.; Pan, X.; et al. A Rare Genetic Defect of MBL2 Increased the Risk for Progression of IgA Nephropathy. Front. Immunol. 2019, 10, 537. [Google Scholar] [CrossRef]
  37. Giang, N.T.; van Tong, H.; Quyet, D.; Hoan, N.X.; Nghia, T.H.; Nam, N.M.; Hung, H.V.; Anh, D.T.; Van Mao, C.; Son, H.A.; et al. Complement Protein Levels and MBL2 Polymorphisms Are Associated with Dengue and Disease Severity. Sci. Rep. 2020, 10, 14923. [Google Scholar] [CrossRef] [PubMed]
  38. Toivonen, L.; Vuononvirta, J.; Mertsola, J.; Waris, M.; He, Q.; Peltola, V. Polymorphisms of Mannose-Binding Lectin and Toll-like Receptors 2, 3, 4, 7 and 8 and the Risk of Respiratory Infections and Acute Otitis Media in Children. Pediatr. Infect. Dis. J. 2017, 36, e114–e122. [Google Scholar] [CrossRef] [PubMed]
  39. Bujalkova, M.; Zavodna, K.; Krivulcik, T.; Ilencikova, D.; Wolf, B.; Kovac, M.; Karner-Hanusch, J.; Heinimann, K.; Marra, G.; Jiricny, J.; et al. Multiplex SNaPshot Genotyping for Detecting Loss of Heterozygosity in the Mismatch-Repair Genes MLH1 and MSH2 in Microsatellite-Unstable Tumors. Clin. Chem. 2008, 54, 1844–1854. [Google Scholar] [CrossRef]
  40. Mehta, B.; Daniel, R.; Phillips, C.; McNevin, D. Forensically Relevant SNaPshot® Assays for Human DNA SNP Analysis: A Review. Int. J. Leg. Med. 2017, 131, 21–37. [Google Scholar] [CrossRef]
  41. Garred, P.; Strøm, J.J.; Quist, L.; Taaning, E.; Madsen, H.O. Association of Mannose-Binding Lectin Polymorphisms with Sepsis and Fatal Outcome, in Patients with Systemic Inflammatory Response Syndrome. J. Infect. Dis. 2003, 188, 1394–1403. [Google Scholar] [CrossRef]
  42. Skalníková, H.; Freiberger, T.; Chumchalová, J.; Grombiříková, H.; Šedivá, A. Cost-Effective Genotyping of Human MBL2 Gene Mutations Using Multiplex PCR. J. Immunol. Methods 2004, 295, 139–147. [Google Scholar] [CrossRef]
  43. de Araujo, F.J.; Mesquita, T.G.; da Silva, L.D.O.; de Almeida, S.A.; de S Vital, W.; Chrusciak-Talhari, A.; de O Guerra, J.A.; Talhari, S.; Ramasawmy, R. Functional Variations in MBL2 Gene Are Associated with Cutaneous Leishmaniasis in the Amazonas State of Brazil. Genes Immun. 2015, 16, 284–288. [Google Scholar] [CrossRef]
  44. Speletas, M.; Gounaris, A.; Sevdali, E.; Kompoti, M.; Konstantinidi, K.; Sokou, R.; Tsitsami, E.; Germenis, A.E. MBL2 Genotypes and Their Associations with MBL Levels and NICU Morbidity in a Cohort of Greek Neonates. J. Immunol. Res. 2015, 2015, 1–10. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Munthe-Fog, L.; Madsen, H.O.; Garred, P. Genotyping of FCN and MBL2 Polymorphisms Using Pyrosequencing. In The Complement System; Gadjeva, M., Ed.; Methods in Molecular Biology; Humana Press: Totowa, NJ, USA, 2014; Volume 1100, pp. 123–130. ISBN 978-1-62703-723-5. [Google Scholar]
  46. Konopac, M.; Dusatkova, P.; Cinek, O. SNPman: A Program for Genotype Calling Using Run Data from TaqMan Allelic Discrimination. Bioinformatics 2011, 27, 2306–2308. [Google Scholar] [CrossRef] [Green Version]
  47. Ito, T.; Inoue, E.; Kamatani, N. Association Test Algorithm Between a Qualitative Phenotype and a Haplotype or Haplotype Set Using Simultaneous Estimation of Haplotype Frequencies, Diplotype Configurations and Diplotype-Based Penetrances. Genetics 2004, 168, 2339–2348. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Zuo, L.; Wang, K.; Luo, X. Use of Diplotypes—Matched Haplotype Pairs from Homologous Chromosomes—in Gene-Disease Association Studies. Shanghai Arch. Psychiatry 2014, 26, 165–170. [Google Scholar] [CrossRef]
  49. Tsujimoto, S.; Osumi, T.; Uchiyama, M.; Shirai, R.; Moriyama, T.; Nishii, R.; Yamada, Y.; Kudo, K.; Sekiguchi, M.; Arakawa, Y.; et al. Diplotype Analysis of NUDT15 Variants and 6-Mercaptopurine Sensitivity in Pediatric Lymphoid Neoplasms. Leukemia 2018, 32, 2710–2714. [Google Scholar] [CrossRef]
  50. Al Bkhetan, Z.; Zobel, J.; Kowalczyk, A.; Verspoor, K.; Goudey, B. Exploring Effective Approaches for Haplotype Block Phasing. BMC Bioinform. 2019, 20, 540. [Google Scholar] [CrossRef]
  51. Browning, S.R.; Browning, B.L. Haplotype Phasing: Existing Methods and New Developments. Nat. Rev. Genet. 2011, 12, 703–714. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Purcell, S.; Neale, B.; Todd-Brown, K.; Thomas, L.; Ferreira, M.A.R.; Bender, D.; Maller, J.; Sklar, P.; de Bakker, P.I.W.; Daly, M.J.; et al. PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses. Am. J. Hum. Genet. 2007, 81, 559–575. [Google Scholar] [CrossRef] [Green Version]
  53. Excoffier, L.; Lischer, H.E.L. Arlequin Suite Ver 3.5: A New Series of Programs to Perform Population Genetics Analyses under Linux and Windows. Mol. Ecol. Resour. 2010, 10, 564–567. [Google Scholar] [CrossRef]
  54. Kim, S.; Park, K.; Shin, C.; Cho, N.H.; Ko, J.-J.; Koh, I.; Kwack, K. Diplotyper: Diplotype-Based Association Analysis. BMC Med. Genom. 2013, 6, S5. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Kavrikova, D.; Borilova Linhartova, P.; Lucanova, S.; Poskerova, H.; Fassmann, A.; Izakovicova Holla, L. Chemokine Receptor 2 (CXCR2) Gene Variants and Their Association with Periodontal Bacteria in Patients with Chronic Periodontitis. Mediat. Inflamm. 2019, 2019, 1–8. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Electropherograms of three samples showing peaks of all alleles. Alleles of individual single nucleotide polymorphisms (SNPs) are highlighted by color line or rectangle (yellow–allele A/B, green–allele A/C, red–allele X/Y, blue–allele A/D, orange–allele H/L, black–allele P/Q).
Figure 1. Electropherograms of three samples showing peaks of all alleles. Alleles of individual single nucleotide polymorphisms (SNPs) are highlighted by color line or rectangle (yellow–allele A/B, green–allele A/C, red–allele X/Y, blue–allele A/D, orange–allele H/L, black–allele P/Q).
Diagnostics 11 00301 g001
Table 1. Demographic data of 328 individuals with good systemic health who enrolled in this study; all were selected from the Czech population.
Table 1. Demographic data of 328 individuals with good systemic health who enrolled in this study; all were selected from the Czech population.
Characteristicsn = 328
Total
n = 192
Female
n = 136
Male
Age (mean ± SD, median, IQR) in years34.0 ± 13.5,
30.0, 23.0–43.0
34.0 ± 14.3,
27.0, 22.0–44.5
34.1 ± 12.2,
31.0, 25.0–41.0
IQR, interquartile range; n, number of subjects; SD, standard deviation.
Table 2. Primers used in the single-base extension (SBE) reaction for determining the mannose-binding lectin gene (MBL2) single nucleotide polymorphisms (SNPs).
Table 2. Primers used in the single-base extension (SBE) reaction for determining the mannose-binding lectin gene (MBL2) single nucleotide polymorphisms (SNPs).
Rs
Number
Nucleotide Substitution 1
(Location, Amino Acid
Substitution/SNP Position 2)
AllelePrimer Sequence (5’→ 3’)DNA StrandConcentration of the Primer in the SBE Primer Mix (μM)
rs1800450161G>A
(exon 1, Gly54Asp)
A/BCCAGGCAAAGATGGGYGTGATG 3forward0.1
rs1800451170G>A
(exon 1, Gly57Glu)
A/CTTTTACGTACCTGGTTCCCCCTTTTCTreverse0.18
rs7096206−290C>G
(promoter, -221 2)
X/YTTTTTTTTGGTCCCATTTGTTCTCACTGCCACforward0.06
rs5030737154C>T
(exon 1, Arg52Cys)
A/DTTTTTTTTTTTTCCCTTTTCTYCCTTGGTGYCATCAC 3reverse0.08
rs11003125−619C>G
(promoter, -550 2)
H/LTTTTTTTTTTTTTTTTGGAGTTTGCTTCCCCTTGGTGTTTTAreverse0.08
rs7095891−66C>T
(5’ UTR of exon 1, +4 2)
P/QTTTTTTTTCAGGGAAGGTTAATCTCAGTTAATGAACACATATTTACCreverse0.06
1 Single nucleotide polymorphism (SNP) position according to the database NCBI dbSNP HGVS (Human Genome Variation Society) names NM_000242.2:c entry; 2 SNP position used in the literature, e.g., Garred et al. [8] or Świerzko and Cedzyński [18]; 3 Letter Y in the primer sequence indicates a site containing a degenerate base (cytosine or thymine). Single-base extension (SBE).
Table 3. Minor allele frequencies (MAFs) of mannose-binding lectin gene (MBL2) single nucleotide polymorphisms (SNPs) in a genotyped sample pool of Czech healthy individuals and in European (EUR), African (AFR), East Asian (EAS), South Asian (SAS) and American (AMR) populations according to NCBI database dbSNP (https://www.ncbi.nlm.nih.gov/snp/ (accessed on 2 November 2020)).
Table 3. Minor allele frequencies (MAFs) of mannose-binding lectin gene (MBL2) single nucleotide polymorphisms (SNPs) in a genotyped sample pool of Czech healthy individuals and in European (EUR), African (AFR), East Asian (EAS), South Asian (SAS) and American (AMR) populations according to NCBI database dbSNP (https://www.ncbi.nlm.nih.gov/snp/ (accessed on 2 November 2020)).
rs NumberAlleleMAF (%)
n = 328
Czech
n = 1006
EUR
n = 1322
AFR
n = 1008
EAS
n = 978
SAS
n = 694
AMR
rs11003125H38.338.68.744.631.040.0
rs7096206X21.422.115.418.628.013.0
rs7095891Q23.619.854.013.825.017.0
rs5030737D8.56.00.20.15.03.0
rs1800450B13.514.11.414.815.022.0
rs1800451C1.81.225.90.04.02.0
n, number of subjects.
Table 4. Mannose-binding lectin gene (MBL2) haplotype frequencies in a genotyped sample pool of 328 Czech and 100 Danish healthy individuals.
Table 4. Mannose-binding lectin gene (MBL2) haplotype frequencies in a genotyped sample pool of 328 Czech and 100 Danish healthy individuals.
MBL2 Haplotype 1Combination of Alleles (Secretor Haplotype)MBL Phenotype 2Frequency in Czech Population (%)Frequency in Danish Population 3 (%)
G G C C G GHYPAHigh29.828.5
C G T C G GLYQAHigh21.723.5
C C C C G GLXPALow21.419.5
C G C C A GLYPBUndetectable13.313.5
G G C T G GHYPDUndetectable8.58.5
C G C C G GLYPAIntermediate3.34.5
C G T C G ALYQCUndetectable1.82.0
C G T C A GLYQBUndetectable0.2-
1 rs11003125, rs7096206, rs7095891, rs5030737, rs1800450, rs1800451; 2 According to Cedzyński et al. and Verdu et al. [4,11]; 3 According to Steffensen et al. [20].
Table 5. Mannose-binding lectin gene (MBL2) haplogenotype distribution among samples from 328 healthy Czech individuals.
Table 5. Mannose-binding lectin gene (MBL2) haplogenotype distribution among samples from 328 healthy Czech individuals.
MBL2 Haplogenotype 1Combination of Secretor Haplotypes 2Frequency (%)
GC GG CT CC GG GGHYPA/LYQA16.2
GC GC CC CC GG GGHYPA/LXPA11.9
CC GC CT CC GG GGLYQA/LXPA10.1
GG GG CC CC GG GGHYPA/HYPA7.9
GC GG CC CC GA GGHYPA/LYPB7.3
CC GG CT CC GA GGLYQA/LYPB6.1
CC CC CC CC GG GGLXPA/LXPA5.5
GG GG CC CT GG GGHYPA/HYPD5.2
CC GC CC CC GA GGLXPA/LYPB4.0
CC GG TT CC GG GGLYQA/LYQA3.7
GC GG CC CT GA GGLYPB/HYPD3.0
GC GC CC CT GG GGLXPA/HYPD3.0
GC GG CT CT GG GGLYQA/HYPD2.4
GC GG CC CC GG GGHYPA/LYPA2.4
CC GG CC CC AA GGLYPB/LYPB2.1
CC GC CT CC GG GALXPA/LYQC1.8
CC GG CC CC GA GGLYPB/LYPA1.2
CC GG CT CC GG GGLYQA/LYPA1.2
GC GG CC CT GG GGHYPD/LYPA0.9
CC GC CC CC GG GGLXPA/LYPA0.9
GG GG CC TT GG GGHYPD/HYPD0.9
GC GG CT CC GG GAHYPA/LYQC0.6
CC GG CT CC GA GALYPB/LYQC0.6
CC GG TT CC GG GALYQA/LYQC0.3
GC GG CT CT GG GAHYPD/LYQC0.3
GC GG CT CC GA GGHYPA/LYQB0.3
1 rs11003125, rs7096206, rs7095891, rs5030737, rs1800450, rs1800451; 2 Translated from the haplogenotypes.
Table 6. Comparison of methods used for mannose-binding lectin gene (MBL2) genotyping.
Table 6. Comparison of methods used for mannose-binding lectin gene (MBL2) genotyping.
Allele
-Specific PCR
(AS-PCR)
ARMS 3/Double
ARMS 3
(+
Multiplex Allele
-Specific PCR)
PCR and Restriction-Fragment Length Polymorphism
(PCR-RFLP)
Commercial
TaqMan
Assay 5
High-Resolution Melt Analysis
(HRMA)
Commercial
INNO-LiPA
MBL2 kit
(Reverse
PCR-SSOP)
Pyro-
Sequencing
Sanger
Sequencing
MBL2
SNaPshot
Assay
principle of allele discrimination/detectionPCR with a primer specific for one allelePCR with primers specific for both allelesallele-specific enzymatic cleavage of PCR ampliconallele-specific hybridization of fluorescently labelled probetemperature-dependent allele-specific hybridization of fluorescently labelled probehybridization of biotinylated PCR product with membrane immobilized sequence-specific oligonucleotide probeschemiluminiscence-based detection of nucleotides during sequencing-by-synthesis reactiondetection of the sequence of an oligonucleotide amplified in PCR with fluorescently labelled dideoxyribonucleotidesallele-specific SBE by a single fluorescently labelled dideoxyribonucleotide (minisequencing)
post-PCR analysisyesyesyesnono, when real-time PCR thermocycler
is used
yesnoyesyes
analysis time2 h 22–3 h 22 h
+
1–3 h 4
1–2 h 61–1.5 h
+
2–8 min. 8
3–4 h2–3 h6–7 h5–6 h
number of work steps2
(PCR, gel analysis)
2
(PCR, gel analysis)
4
(PCR, gel analysis, RFLP, gel analysis)
1
(real-time PCR)
1
(when real-time PCR thermocycler
is used for PCR and subsequent melting temperature analysis)
9
(PCR, gel analysis, denaturation, hybridization, 2 washing steps, 3-step color development)
4
(PCR, gel analysis, purification, pyrosequencing)
5
(PCR, enzymatic cleaning, sequencing reaction, purification, analysis on sequencer)
5
(PCR, enzymatic cleaning, SBE reaction, enzymatic cleaning, analysis on sequencer)
automatic analysisnononoyesyesnoyesyesyes
number of analyses for complete MBL2 haplogenotype 112666514 921
number of oligonucleotide primers + labelled primers/probes
for complete MBL2 haplogenotype 1
24 primers15 primers6 primers6 TaqMan assays (12 primers + 12 TaqMan probes)10 primers + 5 TaqMan probes4 primers8 primers + 4 biotinylated primers2 primers8 primers
estimated cost of analysis of whole haplogenotype 11 USD1 USD2 USD2 USD1 USDproduct was discontinued2 USD5 USD1.50 USD
input amount
of template DNA
20–200 ng20–200 ng50–500 ng1–20 ng10–20 ng200–500 ng10–100 ng10–250 ng10–100 ng
assay robustnesslowlowlow–mediummedium–highhighlow–medium mediummedium–highmedium–high
special equipment requirement---real-time PCR thermocyclerreal-time PCR thermocycler
or fluorescence scanning/detection system
water bath with shaking platform, aspiration apparatusvacuum prep workstation, pyrosequencing machineautomated DNA sequencerautomated DNA sequencer
SNP genotyping throughputlowlowlowhighhighmediumhighhighhigh
software for automatic allele callingnononoyes
(SDS software, SNPman program) 7
yes
real-time PCR instruments with HRMA compatible software with
genotype auto-calling function
nonoyes
(Mutation Surveyor, GeneMarker, Minor Variant Finder Software, SeqScape™ Software, Variant Reporter™ Software) 10
yes
(GeneMapper, GeneMarker) 11
Ref.[41][30,42][43,44][27][28][29][45][37]-
1 rs11003125, rs7096206, rs7095891, rs5030737, rs1800450 and rs1800451; 2 Analysis time depends on polymerase chain reaction (PCR) length and gel concentration; 3 ARMS–amplification refractory mutation system; 4 Separation time depends on gel concentration and the length of cleaved fragments; 5 TaqMan® SNP Genotyping Assays (Applied Biosystems), probes: C__11876879_10 (rs11003125), C__27858274_10 (rs7096206), C__26813436_10 (rs7095891), C___2336610_10 (rs5030737), C___2336609_20 (rs1800450) and C___2336608_20 (rs1800451); 6 depends on number of cycles; 7 Sequence Detection Software (SDS) by Applied Biosystems™ (www.thermofisher.com (accessed on 2 November 2020)), SNPman program by Konopac et al. [46]; 8 Time of temperature melt analysis depends on a temperature range and thermal ramp rate of the instrument; 9 Due to the proximity of the three single nucleotide polymorphisms (SNPs) in exon 1 only one analysis is needed to determine these SNPs; 10 Mutation Surveyor® and GeneMarker® by SoftGenetics® (https://softgenetics.com (accessed on 2 November 2020)). Minor Variant Finder Software, SeqScape™ Software and Variant Reporter™ Software by Applied Biosystems™ (www.thermofisher.com (accessed on 2 November 2020)); 11 GeneMapper™ by Applied Biosystems™ (www.thermofisher.com (accessed on 2 November 2020)), GeneMarker® by SoftGenetics® (https://softgenetics.com (accessed on 2 November 2020)). Single-base extension (SBE). Mannose-binding lectin gene (MBL2). Reverse hybridization with membrane-immobilized sequence-specific oligonucleotide probes (reverse PCR-SSOP).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Mrazkova, J.; Sistek, P.; Lochman, J.; Izakovicova Holla, L.; Danek, Z.; Borilova Linhartova, P. A SNaPshot Assay for Determination of the Mannose-Binding Lectin Gene Variants and an Algorithm for Calculation of Haplogenotype Combinations. Diagnostics 2021, 11, 301. https://doi.org/10.3390/diagnostics11020301

AMA Style

Mrazkova J, Sistek P, Lochman J, Izakovicova Holla L, Danek Z, Borilova Linhartova P. A SNaPshot Assay for Determination of the Mannose-Binding Lectin Gene Variants and an Algorithm for Calculation of Haplogenotype Combinations. Diagnostics. 2021; 11(2):301. https://doi.org/10.3390/diagnostics11020301

Chicago/Turabian Style

Mrazkova, Jana, Petr Sistek, Jan Lochman, Lydie Izakovicova Holla, Zdenek Danek, and Petra Borilova Linhartova. 2021. "A SNaPshot Assay for Determination of the Mannose-Binding Lectin Gene Variants and an Algorithm for Calculation of Haplogenotype Combinations" Diagnostics 11, no. 2: 301. https://doi.org/10.3390/diagnostics11020301

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop